We are live on
!
Find out more
BIOS
BioPlus Acquisition Corp. Class A Ordinary Shares
BIOS
BIOS
Delisted
BIOS was delisted on the 6th of October, 2023.
30 hedge funds and large institutions have $135M invested in BioPlus Acquisition Corp. Class A Ordinary Shares in 2023 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 4 increasing their positions, 3 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
33% more repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 3
1% more capital invested
Capital invested by funds: $134M → $135M (+$1.36M)
6% less funds holding
Funds holding: 32 → 30 (-2)
33% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 6
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
30
Holders Change
-2
Holders Change %
-6.25%
% of All Funds
0.48%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
4
Increased
4
Reduced
3
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
CAC
Cowen and Company
New York
|
+$7.29M |
| 2 |
WRBC
W.R. Berkley Corp
Greenwich,
Connecticut
|
+$5.6M |
| 3 |
BCM
BCK Capital Management
Stamford,
Connecticut
|
+$797K |
| 4 |
WAM
Wolverine Asset Management
Chicago,
Illinois
|
+$392K |
| 5 |
VF
Virtu Financial
New York
|
+$219K |
Top Sellers
| 1 |
QL
Quarry LP
New York
|
-$4.85M |
| 2 |
MSU
Mizuho Securities USA
New York
|
-$3.64M |
| 3 |
SFM
Spartan Fund Management
Toronto, Ontario,
Canada
|
-$3.41M |
| 4 |
PCM
Prelude Capital Management
New York
|
-$1.6M |
| 5 |
OCM
Oaktree Capital Management
Los Angeles,
California
|
-$1.06M |
